Analgesic and anti-inflammatory activity of podophyllotoxin derivatives

Pharmaceutical Biology

Volumn 51, Issue 5, 2013, Pages 566-572

  Guerrero, Estela ^a   Abad, Andrés ^b   Montenegro, Gisela ^a   Del Olmo, Esther ^c   López Pérez, José Luis ^c   San Feliciano, Arturo ^c  

^a UNIVERSIDAD DE PANAMÁ   (Panama)

^b FACULTAD DE CIENCIAS   (Venezuela)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Deoxypicropodophyllin; Deoxypodophyllotoxin; Thuriferic acid

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; DEOXYPICROPODOPHYLLIN; DEOXYPICROPODOPHYLLOTOXIN; DEOXYPODOPHYLLOTOXIN; INDOMETACIN; MORPHINE; PODOPHYLLOTOXIN; PODOPHYLLOTOXIN DERIVATIVE; THURIFERIC ACID; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL; CELL STRAIN; CELL STRAIN A 549; CELL STRAIN HT 29; CONCENTRATION RESPONSE; CONTROLLED STUDY; CUPRESSACEAE; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INFLAMMATION; JUNIPERUS THURIFERA; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PHYTOCHEMISTRY; PLANT LEAF; RAT; TUMOR CELL P 388;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTINEOPLASTIC AGENTS; CARBAZOLES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; HT29 CELLS; HUMANS; INDOMETHACIN; INFLAMMATION; JUNIPERUS; MALE; MICE; NAPHTHALENES; NEOPLASMS; PAIN; PLANT LEAVES; PODOPHYLLOTOXIN;

CUPRESSACEAE; JUNIPERUS THURIFERA; MUS;

EID: 84876589832     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.749921     Document Type: Article

References (31)

1. Allinger NL. (1977). Conformational-analysis.130. MM2-hydrocarbon force-field utilizing V1 and V2 torsional terms. J Am Chem Soc 99: 8127-34.
2. Baker Z, Davison C, Smith P. (1950). The effect of podophyllotoxin, colchicines, urethane, and nitrogen mustard on the respiration of normal and suprarenalectomized rat lymphatic tissue. J Exp Med 92: 113-19.
3. Chang H, Shyu KG, Lee CC, et al. (2003). GL331 inhibits HIF-1alpha expression in a lung cancer model. Biochem Biophys Res Commun 302: 95-100. (Pubitemid 36268924)
4. Collier HO, Dinneen LC, Johnson CA, Schneider C. (1968). The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol Chemother 32: 295-310.
5. Deraedt R, Jouquey S, Delevallee F, Flahaut M. (1980). Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 61: 17-24. (Pubitemid 10178021)
6. Dewick PM, Jackson DE. (1981). Cytotoxic lignans from podophyllum, and the nomenclature of aryltetralin lignans. Phytochemistry 20: 2277-80.
7. Dumontet C, Jordan MA. (2010). Microtubule-binding agents: A dynamic field of cancer therapeutics. Nat Rev Drug Discov 9: 790-803.
8. Guay J, Bateman K, Gordon R, et al. (2004). Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1. J Biol Chem 279: 24866-72. (Pubitemid 38725355)
9. Haasnoot CAG, Deleeuw F, Altona C. (1980). The relationship between proton-proton NMR coupling-constants and substituent electronegativities. 1: an empirical generalization of the Karplus equation. Tetrahedron 36: 2783-92.
10. Hande KR. (1998). Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur J Cancer 34: 1514-21. (Pubitemid 28446331)
11. Hartwell JL, Schrecker AW. (1958). The chemistry of podophyllum. Fortschr Chem Org Naturst 15: 83-166.
12. Jackson JK, Higo T, Hunter WL, Burt HM. (2008). Topoisomerase inhibitors as anti-arthritic agents. Inflamm Res 57: 126-34.
13. Jordan A, Hadfield JA, Lawrence NJ, McGown AT. (1998). Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle. Med Res Rev 18: 259-96. (Pubitemid 28346389)
14. Kluza J, Mazinghien R, Irwin H, et al. (2006). Relationships between DNA strand breakage and apoptotic progression upon treatment of HL-60 leukemia cells with tafluposide or etoposide. Anticancer Drugs 17: 155-64.
15. López-Pérez JL, del Olmo E, de Pascual-Teresa B, et al. (1995). Unambiguous configurational and conformational determination of thuriferic acid. Tetrahedron 51: 6343-8.
16. López-Pérez JL, Therón R, del Olmo E, D́az D. (2007). NAPROC-13: a database for the dereplication of natural product mixtures in bioassayguided protocols. Bioinformatics 23: 3256-7. (Pubitemid 350187534)
17. Meresse P, Dechaux E, Monneret C, Bertounesque E. (2004). Etoposide: Discovery and medicinal chemistry. Curr Med Chem 11: 2443-66. (Pubitemid 39172359)
18. Mohamadi F, Richards NGJ, Guida WC, et al. (1990). Macro-model-An integrated software system for modeling organic and bioorganic molecules using molecular mechanics. J Comput Chem 11: 440-67.
19. Moraes RM, Lata H, Bedir E, et al. (2002) The American mayapple and its potential for podophyllotoxin production. In: Janick J, Whipkey A, eds. Trends in New Crops and New Uses. Alexandria, Virginia: ASHS Press, 527-32.
20. Rassmann I, Thodtmann R, Mross M, et al. (1998). Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion. Invest New Drugs 16: 319-24. (Pubitemid 29281100)
21. Ribeiro RA, Vale ML, Thomazzi SM, et al. (2000). Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 387: 111-18. (Pubitemid 30035382)
22. San Feliciano A, Gordaliza M, Miguel del Corral, JM, et al. (1993). Antineoplastic and antiviral activities of some cyclolignans. Planta Med 59: 246-9. (Pubitemid 23168772)
23. San Feliciano A, López JL, Medarde M, et al. (1988). Thuriferic acid. A novel lignan type from Juniperus thurifera L. Tetrahedron 44: 7255-60.
24. San Feliciano A, Medarde M, Lopez JL, et al. (1989). Lignans from Juniperus thurifera L. Phytochemistry 28: 2863-6.
25. Schacter L. (1996). Etoposide phosphate: What, why, where, and how Semin Oncol 23: 1-7.
26. Stahelin H, von Wartburg A. (1989). From podophyllotoxin glucoside to etoposide. Prog Drug Res 33: 169-266. (Pubitemid 19275354)
27. Svensson B, Pettersson H. (2003). Reumacon (CPH82) showed similar X-ray progression and clinical effects as methotrexate in a two years comparative study on patients with early rheumatoid arthritis. Scand J Rheumatol 32: 83-8. (Pubitemid 36428345)
28. Winter CA, Risley EA, Nuss GW. (1962). Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc Soc Exp Biol Med 111: 544-7.
29. You Y. (2005). Podophyllotoxin derivatives: Current synthetic approaches for new anticancer agents. Curr Pharm Des 11: 1695-717. (Pubitemid 40668145)
30. Zakaria ZA, Ghani ZD, Nor RN, et al. (2008). Antinociceptive, antiinflammatory, and antipyretic properties of an aqueous extract of Dicranopteris linearis leaves in experimental animal models. J Nat Med 62: 179-87.
31. Zimmermann M. (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-10. (Pubitemid 13058546)